Healthcare Sector

PFE

Market Tracker

$25.52
-0.01
(-0.04%)
10:40 pm
Next Earnings: (est.) 08/01/23 12:00 am
  • PFE (Selected)

    Pfizer Inc.
  • PFEB

    Innovator S&P 500 Power Buffer ETF - February

PFE Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

PFE Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

PFE Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

PFE Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

PFE Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

PFE Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
12/19/2025 PUT $22.50 86,637 +35,313 +68.80%
12/19/2025 CALL $27.00 33,764 +6,533 +23.99%
12/19/2025 CALL $26.50 24,054 +5,086 +26.81%
01/16/2026 PUT $26.00 14,141 +4,743 +50.47%
02/20/2026 CALL $30.00 7,422 +3,998 +116.76%
12/19/2025 CALL $28.00 7,741 +2,719 +54.14%
01/16/2026 PUT $24.00 21,348 -346 -1.59%
06/18/2026 CALL $30.00 30,306 -814 -2.62%
12/19/2025 PUT $25.00 72,538 -823 -1.12%
12/19/2025 CALL $26.00 85,054 -1,021 -1.19%
01/16/2026 PUT $25.00 60,631 -1,220 -1.97%
12/19/2025 CALL $29.00 30,558 -5,683 -15.68%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

PFE Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.02% 170.64M 6.14B
Vanguard 500 Index Fund 2.30% 129.76M 4.67B
Washington Mutual Investors Fund 1.42% 80.41M 2.89B
Fidelity 500 Index Fund 1.09% 61.54M 2.21B
SPDR S&P 500 ETF Trust 1.08% 60.77M 2.19B
American Balanced Fund 1.00% 56.61M 2.04B
Income Fund of America Inc 0.93% 52.68M 1.9B
iShares Core S&P 500 ETF 0.89% 50.1M 1.8B
Vanguard Index-Value Index Fund 0.86% 48.51M 1.75B
Vanguard Specialized-Health Care Fund 0.86% 48.32M 1.74B

PFE News

  • S&P 500 Stays Range-Bound as NFP Cools Without Forcing Panic Fed Cuts

    12/16 03:16 pm

    Investing.com

    Read more
  • 1 Bold Prediction for Viking Therapeutics in 2026

    12/16 02:15 pm

    The Motley Fool

    Read more
  • Pfizer Sees Slower 2026 Growth Despite Pipeline Push, Cost Cuts

    12/16 10:28 am

    Benzinga

    Read more
  • Pfizer: Can $108B Bet on Obesity Drugs Revive Its Struggling Stock?

    12/16 08:30 am

    Investing.com

    Read more
  • Where Will Eli Lilly Be in 10 Years?

    12/16 06:15 am

    The Motley Fool

    Read more
  • Pfizer Faces Another Quiet Year As Patent Losses Cloud 2026 Outlook: Analyst

    12/15 01:31 pm

    Benzinga

    Read more
  • Will Dogecoin Reach $1 By the End of the Year?

    12/15 07:15 am

    The Motley Fool

    Read more
  • Should You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead?

    12/14 04:27 pm

    The Motley Fool

    Read more
  • Women’s Healthcare Market Worth USD 46.76 Billion by 2033 Driven by Rising Demand for Reproductive, Preventive, and Digital Health Solutions – SNS Insider

    12/13 09:10 pm

    GlobeNewswire Inc.

    Read more
  • 3SBio Sells Shares, Divests Subsidiary To Boost Capital

    12/11 07:22 am

    Benzinga

    Read more
  • Warning: This Skyrocketing Stock Has a Hidden Risk

    12/10 05:15 pm

    The Motley Fool

    Read more
  • Alameda Health System wins equity award for breast cancer screening campaign

    12/10 04:39 pm

    GlobeNewswire Inc.

    Read more
  • Pfizer's Tukysa Combo Shows Strong PFS Benefit In Metastatic Breast Cancer

    12/10 02:20 pm

    Benzinga

    Read more
  • Down 50%, Should You Buy the Dip on Pfizer?

    12/09 05:15 pm

    The Motley Fool

    Read more
  • Arcutis Strengthens Board of Directors with New Appointment of Amit Munshi and Honors Retirement of Bhaskar Chaudhuri

    12/08 05:00 pm

    GlobeNewswire Inc.

    Read more
  • Autism Spectrum Disorder Market to Reach USD 4.07 Billion by 2033, Driven by Rising Awareness, Early Diagnosis & Advances in Personalized Therapeutics | SNS Insider

    12/07 09:43 am

    GlobeNewswire Inc.

    Read more
  • Ophthalmic Drugs Market Size to Cross USD 62.74 Billion by 2032, Driven by Advances in Eye Care Treatments and Rising Global Vision Disorders - SNS Insider

    12/07 09:05 am

    GlobeNewswire Inc.

    Read more
  • Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition

    12/06 10:30 am

    GlobeNewswire Inc.

    Read more
  • Peptide Therapeutics Market Size to Reach USD 82.19 Billion by 2032; Surging Requirements for Targeted Medicines in Oncology Augment Market Expansion - SNS Insider

    12/06 10:10 am

    GlobeNewswire Inc.

    Read more
  • Do These 3 Healthcare Stocks Need a Checkup?

    12/05 05:05 pm

    The Motley Fool

    Read more
  • Is This Pharmaceutical Giant a Buy After a Major Acquisition?

    12/05 01:05 pm

    The Motley Fool

    Read more
  • Sickle Cell Disease Market is Predicted to Exhibit Remarkable Growth at a CAGR of 22.1% During the Forecast Period (2025–2034) Across 6MM, Owing to the Increasing Prevalence, Awareness, and Advancements in Gene Therapies | DelveInsight

    12/03 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Seasonal Vaccines Market Accelerating Growth and Rising Opportunities Through 2035

    12/03 11:00 am

    GlobeNewswire Inc.

    Read more
  • Vaccine Development Company Landscape Report 2025: Recent Expansions, Partnerships and Collaborations, Big Pharma Initiatives and Cost Price Analysis

    12/02 05:37 am

    GlobeNewswire Inc.

    Read more
  • Nurix Therapeutics Announces Webcast to Review New and Updated Data from the Phase 1 Clinical Trial of BTK Degrader Bexobrutideg (NX-5948) To Be Presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition

    12/01 08:00 am

    GlobeNewswire Inc.

    Read more
  • 2 Undervalued, High-Quality Companies to Buy Now and Hold Forever

    11/30 10:05 pm

    The Motley Fool

    Read more
  • This 7% Yielder Could Be a Top AI Play

    11/30 05:04 pm

    The Motley Fool

    Read more
  • Atopic Dermatitis Drugs Market to Reach $29.43 Billion by 2032, Driven by Rising Disease Prevalence & Strong Therapeutic Innovation | SNS Insider

    11/28 01:28 am

    GlobeNewswire Inc.

    Read more
  • Geriatric Care Services Market is expected to generate a revenue of USD 2.03 Billion by 2032, Globally, at 7.98% CAGR: Verified Market Research®

    11/27 11:50 pm

    GlobeNewswire Inc.

    Read more
  • Human Growth Hormone Injection Market Size Expected to Reach USD 8.54 Bn by 2035

    11/27 11:00 am

    GlobeNewswire Inc.

    Read more
  • Anti-Obesity Drugs Market Size to Reach $35.52 Billion by 2032, Driven by Advancements in Weight Management Therapies and Rising Obesity Prevalence | SNS Insider

    11/27 08:54 am

    GlobeNewswire Inc.

    Read more
  • Have $2,000 to Invest? Here Are 4 of My Favorite Dividend Stocks for the Next 5 Years

    11/27 05:01 am

    The Motley Fool

    Read more
  • Did Pfizer Just Say "Checkmate" to Novo Nordisk?

    11/26 05:15 am

    The Motley Fool

    Read more
  • Is This the Best Value Stock to Buy While Markets Are Volatile?

    11/25 07:24 am

    The Motley Fool

    Read more
  • Want Over $7,000 in Annual Dividends? Invest $25,000 in Each of These 4 Stocks.

    11/25 06:30 am

    The Motley Fool

    Read more
  • Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium (SABCS)

    11/24 08:00 am

    GlobeNewswire Inc.

    Read more
  • 2 Healthcare Stocks for Beginner Investors With a 20-Year Time Horizon

    11/22 10:20 am

    The Motley Fool

    Read more
  • Pfizer's New mRNA Flu Vaccine Outperforms Traditional Shot Against Predominant Strains

    11/21 11:48 am

    Benzinga

    Read more
  • Is Pfizer's 6.9%-Yielding Dividend Still Safe?

    11/20 10:30 am

    The Motley Fool

    Read more
  • Polycystic Ovary Syndrome Treatment Market Expected to Reach USD 9.12 Bn by 2034

    11/19 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Hospital Care Collaboration and Licensing Agreements Analysis Report and Directory 2025: Upfront, Milestone, and Royalties for 726 Deals by Company A-Z, Therapy Focus and Technology Type

    11/19 11:59 am

    GlobeNewswire Inc.

    Read more
  • Metabolic Collaboration and Licensing Agreements Analysis Report and Directory 2025: Upfront, Milestone, and Royalties for 576 Deals by Company A-Z, Therapy Focus and Technology Type

    11/19 11:58 am

    GlobeNewswire Inc.

    Read more
  • Can AI Drive Peloton's Comeback?

    11/18 03:23 pm

    The Motley Fool

    Read more
  • Novo Nordisk's New Chair Aims To Reinforce Board As Foundation Tightens Control

    11/17 11:11 am

    Benzinga

    Read more
  • This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000?

    11/17 06:25 am

    The Motley Fool

    Read more
  • Down 55%, Should You Buy the Dip on Pfizer?

    11/17 05:35 am

    The Motley Fool

    Read more
  • Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run

    11/13 12:10 pm

    Benzinga

    Read more
  • Santa Claus Rally: 3 Discounted Stocks Heading Into 2026

    11/12 01:35 pm

    Investing.com

    Read more
  • Novo Nordisk's $100 Million Coramitug Shows Promise In Reducing Heart Failure Biomarker

    11/12 10:24 am

    Benzinga

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: